CLASS II ONGOING Drug recall · Reported 22 Apr 2026 · FDA Enforcement Report

Desmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalled

Apotex is recalling Desmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses), distributed nationwide in the US. The recall was initiated on 8 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: VM4231, Exp 06/30/2027

Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-0510-2026
FDA event ID: 98736
Recalling firm: Apotex, Weston, FL
Classification: Class II
Status: Ongoing
Recall initiated: 8 Apr 2026
FDA classified: 1 May 2026
Reported: 22 Apr 2026
Type: Voluntary: Firm initiated
Customers notified by: E-Mail
Reason category: Other Reasons
Drug class: Nasal Sprays

Timeline

8 Apr 2026	Recall initiated by company
22 Apr 2026	Published in enforcement report	+14 days
1 May 2026	Classified by FDA	+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Product as listed by the FDA

Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Which lots are affected?

Lot #: VM4231, Exp 06/30/2027

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Apotex

All 76

Reported	Class	Recall	Company	Reason	Where
7 Oct 2026Drug	CLASS II	Paroxetine Extended-Release Tablets, 37.5mg recalled by ApotexParoxetine Hydrochloride	Apotex	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalled	Apotex	Potency & Assay	Nationwide
25 Mar 2026Drug	CLASS II	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution	Apotex	Sterility	Nationwide
8 Oct 2025Drug	CLASS II	Ketorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac Tromethamine	Apotex	Sterility	Nationwide
8 Oct 2025Drug	CLASS II	Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution	Apotex	Sterility	Nationwide

Other Desmopressin recalls

All 13

Reported	Class	Recall	Company	Reason	Where
14 Dec 2022Drug	CLASS II	Desmopressin Acetate Tablet, 0.2 mg recalled by RemedyRepack	RemedyRepack	Potency & Assay	MI
7 Dec 2022Drug	CLASS II	Desmopressin Acetate Tablets 0.2mg recalled by Heritage PharmaceuticalsDesmopressin Acetate	Heritage Pharmaceuticals	Potency & Assay	Nationwide
6 Jul 2022Drug	CLASS II	Desmopressin Acetate Tablets, 0.2 mg recalled	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	TX
3 Mar 2021Drug	CLASS II	Desmopressin Acetate Injection USP, 4 mcg/mL Preserved Vial recalled	Teva Pharmaceuticals USA	Sterility	Nationwide
26 Aug 2020Drug	CLASS I	Desmopressin Acetate Nasal Spray 10 mcg/ glass vial with spray cap recalled	Ferring Pharmaceuticals	Potency & Assay	Nationwide